HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER) - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Pegylated Interferon Addition to Nucleos(t)ide Analogue Treatment on HBsAg Decline and Clearance: A Meta-Analysis of Individual Participant Data from Prospective Trials (PROSPER)

  • By

  • Edo J Dongelmans

  • Lesley A Patmore

  • Seng Gee Lim

  • Marc Bourliere

  • Shaowen Jiang

  • Nathalie Ganne-Carrie

  • Willem-Pieter Brouwer

  • Jordan J Feld

  • Yuxian Huang

  • Jose A Carrion

  • Teresa Broquetas

  • Qiankun Hu

  • Scott Fung

  • Fabrice Carrat

  • Fabien Zoulim

  • Bettina E Hansen

  • Qing Xie

  • Harry L A Janssen

  • Milan J Sonneveld

  • October 1, 2026

Share

Original Source(s)

HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)

  • by Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, Marc Bourliere, Shaowen Jiang, Nathalie Ganne-Carrie, Willem-Pieter Brouwer, Jordan J Feld, Yuxian Huang, Jose A Carrion, Teresa Broquetas, Qiankun Hu, Scott Fung, Fabrice Carrat, Fabien Zoulim, Bettina E Hansen, Qing Xie, Harry L A Janssen, Milan J Sonneveld

  • October 1, 2026

Related Content

Efficacy and safety of Braun enteroenterostomy in patients undergoing pancreatoduodenectomy: a systematic review and meta-analysis

Probiotics and Risk of Death, Necrotizing Enterocolitis, and Sepsis in Very Preterm Infants

Long-term outcomes in recurrent diverticulitis: a systematic review of treatment strategies and recurrence rates